Cargando…

Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio‐SHiFT study)

BACKGROUND: It is uncertain that chronic heart failure (CHF) patients are susceptible to renal tubular damage with that of worsening renal function (WRF) preceding clinical outcomes. HYPOTHESIS: Changes in tubular damage biomarkers are stronger predictors of subsequent clinical events than changes i...

Descripción completa

Detalles Bibliográficos
Autores principales: Brankovic, Milos, Akkerhuis, K. Martijn, Hoorn, Ewout J., van Boven, Nick, van den Berge, Jan C., Constantinescu, Alina, Brugts, Jasper, van Ramshorst, Jan, Germans, Tjeerd, Hillege, Hans, Boersma, Eric, Umans, Victor, Kardys, Isabella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298997/
https://www.ncbi.nlm.nih.gov/pubmed/32298007
http://dx.doi.org/10.1002/clc.23359
_version_ 1783547314840797184
author Brankovic, Milos
Akkerhuis, K. Martijn
Hoorn, Ewout J.
van Boven, Nick
van den Berge, Jan C.
Constantinescu, Alina
Brugts, Jasper
van Ramshorst, Jan
Germans, Tjeerd
Hillege, Hans
Boersma, Eric
Umans, Victor
Kardys, Isabella
author_facet Brankovic, Milos
Akkerhuis, K. Martijn
Hoorn, Ewout J.
van Boven, Nick
van den Berge, Jan C.
Constantinescu, Alina
Brugts, Jasper
van Ramshorst, Jan
Germans, Tjeerd
Hillege, Hans
Boersma, Eric
Umans, Victor
Kardys, Isabella
author_sort Brankovic, Milos
collection PubMed
description BACKGROUND: It is uncertain that chronic heart failure (CHF) patients are susceptible to renal tubular damage with that of worsening renal function (WRF) preceding clinical outcomes. HYPOTHESIS: Changes in tubular damage biomarkers are stronger predictors of subsequent clinical events than changes in creatinine (Cr), and both have different clinical determinants. METHODS: During 2.2 years, we repeatedly simultaneously collected a median of 9 blood and 8 urine samples per patient in 263 CHF patients. We determined the slopes (rates of change) of the biomarker trajectories for plasma (Cr) and urinary tubular damage biomarkers N‐acetyl‐β‐d‐glucosaminidase (NAG), and kidney‐injury‐molecule (KIM)‐1. The degree of tubular injury was ranked according to NAG and KIM‐1 slopes: increase in neither, increase in either, or increase in both; WRF was defined as increasing Cr slope. The composite endpoint comprised HF‐hospitalization, cardiac death, left ventricular assist device placement, and heart transplantation. RESULTS: Higher baseline NT‐proBNP and lower eGFR predicted more severe tubular damage (adjusted odds ratio, adj. OR [95%CI, 95% confidence interval] per doubling NT‐proBNP: 1.26 [1.07‐1.49]; per 10 mL/min/1.73 m(2) eGFR decrease 1.16 [1.03‐1.31]). Higher loop diuretic doses, lower aldosterone antagonist doses, and higher eGFR predicted WRF (furosemide per 40 mg increase: 1.32 [1.08‐1.62]; spironolactone per 25 mg decrease: 1.76 [1.07‐2.89]; per 10 mL/min/1.73 m(2) eGFR increase: 1.40 [1.20‐1.63]). WRF and higher rank of tubular injury individually entailed higher risk of the composite endpoint (adjusted hazard ratios, adj. HR [95%CI]: WRF 1.9 [1.1‐3.4], tubular 8.4 [2.6‐27.9]; when combined risk was highest 15.0 [2.0‐111.0]). CONCLUSION: Slopes of tubular damage and WRF biomarkers had different clinical determinants. Both predicted clinical outcome, but this association was stronger for tubular injury. Prognostic effects of both appeared independent and additive.
format Online
Article
Text
id pubmed-7298997
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wiley Periodicals, Inc.
record_format MEDLINE/PubMed
spelling pubmed-72989972020-06-18 Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio‐SHiFT study) Brankovic, Milos Akkerhuis, K. Martijn Hoorn, Ewout J. van Boven, Nick van den Berge, Jan C. Constantinescu, Alina Brugts, Jasper van Ramshorst, Jan Germans, Tjeerd Hillege, Hans Boersma, Eric Umans, Victor Kardys, Isabella Clin Cardiol Clinical Investigations BACKGROUND: It is uncertain that chronic heart failure (CHF) patients are susceptible to renal tubular damage with that of worsening renal function (WRF) preceding clinical outcomes. HYPOTHESIS: Changes in tubular damage biomarkers are stronger predictors of subsequent clinical events than changes in creatinine (Cr), and both have different clinical determinants. METHODS: During 2.2 years, we repeatedly simultaneously collected a median of 9 blood and 8 urine samples per patient in 263 CHF patients. We determined the slopes (rates of change) of the biomarker trajectories for plasma (Cr) and urinary tubular damage biomarkers N‐acetyl‐β‐d‐glucosaminidase (NAG), and kidney‐injury‐molecule (KIM)‐1. The degree of tubular injury was ranked according to NAG and KIM‐1 slopes: increase in neither, increase in either, or increase in both; WRF was defined as increasing Cr slope. The composite endpoint comprised HF‐hospitalization, cardiac death, left ventricular assist device placement, and heart transplantation. RESULTS: Higher baseline NT‐proBNP and lower eGFR predicted more severe tubular damage (adjusted odds ratio, adj. OR [95%CI, 95% confidence interval] per doubling NT‐proBNP: 1.26 [1.07‐1.49]; per 10 mL/min/1.73 m(2) eGFR decrease 1.16 [1.03‐1.31]). Higher loop diuretic doses, lower aldosterone antagonist doses, and higher eGFR predicted WRF (furosemide per 40 mg increase: 1.32 [1.08‐1.62]; spironolactone per 25 mg decrease: 1.76 [1.07‐2.89]; per 10 mL/min/1.73 m(2) eGFR increase: 1.40 [1.20‐1.63]). WRF and higher rank of tubular injury individually entailed higher risk of the composite endpoint (adjusted hazard ratios, adj. HR [95%CI]: WRF 1.9 [1.1‐3.4], tubular 8.4 [2.6‐27.9]; when combined risk was highest 15.0 [2.0‐111.0]). CONCLUSION: Slopes of tubular damage and WRF biomarkers had different clinical determinants. Both predicted clinical outcome, but this association was stronger for tubular injury. Prognostic effects of both appeared independent and additive. Wiley Periodicals, Inc. 2020-04-16 /pmc/articles/PMC7298997/ /pubmed/32298007 http://dx.doi.org/10.1002/clc.23359 Text en © 2020 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Investigations
Brankovic, Milos
Akkerhuis, K. Martijn
Hoorn, Ewout J.
van Boven, Nick
van den Berge, Jan C.
Constantinescu, Alina
Brugts, Jasper
van Ramshorst, Jan
Germans, Tjeerd
Hillege, Hans
Boersma, Eric
Umans, Victor
Kardys, Isabella
Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio‐SHiFT study)
title Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio‐SHiFT study)
title_full Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio‐SHiFT study)
title_fullStr Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio‐SHiFT study)
title_full_unstemmed Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio‐SHiFT study)
title_short Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio‐SHiFT study)
title_sort renal tubular damage and worsening renal function in chronic heart failure: clinical determinants and relation to prognosis (bio‐shift study)
topic Clinical Investigations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298997/
https://www.ncbi.nlm.nih.gov/pubmed/32298007
http://dx.doi.org/10.1002/clc.23359
work_keys_str_mv AT brankovicmilos renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy
AT akkerhuiskmartijn renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy
AT hoornewoutj renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy
AT vanbovennick renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy
AT vandenbergejanc renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy
AT constantinescualina renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy
AT brugtsjasper renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy
AT vanramshorstjan renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy
AT germanstjeerd renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy
AT hillegehans renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy
AT boersmaeric renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy
AT umansvictor renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy
AT kardysisabella renaltubulardamageandworseningrenalfunctioninchronicheartfailureclinicaldeterminantsandrelationtoprognosisbioshiftstudy